[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-EP1640373,2006,A1Locationinpatent:Page/Pagecolumn18
[2]Klapars,Artis;Huang,Xiaohua;Buchwald,StephenL.[JournaloftheAmericanChemicalSociety,2002,vol.124,#25,p.7421-7428]
[3]Klapars;Antilla;Huang;Buchwald[JournaloftheAmericanChemicalSociety,2001,vol.123,#31,p.7727-7729]
[1]Cho,Er-Chieh;Liu,Chi-Yuan;Tang,Di-Wei;Lee,Hsueh-Yun[JournalofEnzymeInhibitionandMedicinalChemistry,2021,vol.36,#1,p.1387-1401]
[2]CurrentPatentAssignee:LIFESCIPHARMACEUTICALSINC;ATTUNEPHARMACEUTICALSINC-WO2015/103317,2015,A1Locationinpatent:Page/Pagecolumn191
[3]CurrentPatentAssignee:ABBVIEINC-US2010/160323,2010,A1Locationinpatent:Page/Pagecolumn33-34
[4]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED;ABBVIEINC-US2009/239810,2009,A1Locationinpatent:Page/Pagecolumn90
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101